Dane o zamówieniach publicznych i dotacjach w Europie z oficjalnych rejestrów · Stan danych: 17 listopada 2026, aktualizacja codzienna.

Program dotacji · Stany Zjednoczone

Cancer Detection and Diagnosis Research

Cancer Detection and Diagnosis Research (Stany Zjednoczone): nabory i dotacje programu. Nabory na stronie: 52, w tym otwarte teraz: 10; zwykle otwierane są w listopadzie. Stan danych: 17 listopada 2026, aktualizacja codzienna.

Instytucja finansująca: National Institutes of Health (Department of Health and Human Services)

Dotacje z ostatnich 24 miesięcy
0
Beneficjenci
0
Otwarte nabory
10
Nabory na stronie
52

Nabory otwierane są zwykle w listopadzie

O programie

Objectives: To improve screening and early detection strategies and to develop accurate diagnostic techniques and methods for predicting the course of disease in cancer patients. Screening and Early Detection research includes development of strategies to decrease cancer mortality by finding tumors…

Więcej w źródle

Otwarte nabory

NabórStatusZakończenie naboru
Academic-Industrial Partnerships (AIP) to Translate and Validate In Vivo Imaging Systems (R01 Clinical Trial Optional) (nabór 11.2024 – 01.2027)Otwarty7 stycznia 2027
Glioblastoma Therapeutics Network (GTN) (U19 Clinical Trial Required)Otwarty11 stycznia 2027
Limited Competition: Biospecimen Banks to support NCI National Clinical Trials Network Biospecimen Banks (NCTN Biobanks) and the NCI Early-Phase and Experimental Clinical Trials Biospecimen Bank (EET Biobank) (U24 Clinical Trial Not Allowed)Otwarty11 lutego 2027
Molecular Imaging of Inflammation in Cancer (R01 Clinical Trial Not Allowed) (nabór 11.2024 – 01.2028)Otwarty7 stycznia 2028
Academic-Industrial Partnerships for Translation of Technologies for Diagnosis and Treatment (R01 - Clinical Trial Optional) (nabór 12.2024 – 01.2028)Otwarty7 stycznia 2028
Forecast to Publish a Notice of Funding Opportunity for SBIR Phase IIB Bridge Awards to Accelerate the Development of Cancer-Relevant Technologies Toward Commercialization (R44 Clinical Trial Optional)Planowany—
Early-Stage Innovative Technology Development for Basic and Clinical Cancer Research (R61 Clinical Trial Not Allowed)Planowany—
Advanced Development and Validation of Emerging Technologies for Basic and Clinical Cancer Research (R33 Clinical Trial Not Allowed)Planowany—
Systematic Testing of Radionuclides in Preclinical Experiments (STRIPE, RP1 Clinical Trial Not Allowed)Planowany—
Radiation Oncology-Biology Integration Network (ROBIN) Centers (U54 Clinical Trial Required)Planowany—

Wcześniejsze nabory

NabórStatusZakończenie naboru
Early-Stage Innovative Technology Development for Basic and Clinical Cancer Research (R61 Clinical Trial Not Allowed) (nabór 06.2026 – 11.2026)Zamknięty10 listopada 2026
Advanced Development and Validation of Emerging Technologies for Basic and Clinical Cancer Research (R33 Clinical Trial Not Allowed) (nabór 06.2026 – 11.2026)Zamknięty10 listopada 2026
Revision Applications for Validation of Biomarker Assays Developed Through NIH-Supported Research Grants (R01 Clinical Trial Not Allowed) (nabór 10.2024 – 10.2026)Zamknięty14 października 2026
Assay Validation of High Quality Markers for Clinical Studies in Cancer (UH2/UH3 Clinical Trial Not Allowed) (nabór 10.2024 – 10.2026)Zamknięty14 października 2026
Assay Validation of High Quality Markers for Clinical Studies in Cancer (UH3 Clinical Trials Not Allowed) (nabór 10.2024 – 10.2026)Zamknięty14 października 2026
Innovative Research in Cancer Nanotechnology (IRCN; R01 Clinical Trial Not Allowed) (nabór 11.2024 – 05.2026)Zamknięty4 maja 2026
Revision Applications for Incorporation of Novel NCI-Supported Technology to Accelerate Cancer Research (R01 Clinical Trial Optional) (nabór 12.2024 – 12.2025)Zamknięty9 grudnia 2025
Advanced Development and Validation of Emerging Biospecimen Science Technologies for Basic and Clinical Cancer Research (R33 Clinical Trial Not Allowed) (nabór 12.2024 – 12.2025)Zamknięty9 grudnia 2025
Revision Applications for Incorporation of Novel NCI-Supported Technology to Accelerate Cancer Research (P50 Clinical Trial Optional) (nabór 12.2024 – 12.2025)Zamknięty9 grudnia 2025
Advanced Development and Validation of Emerging Molecular and Cellular Analysis Technologies for Basic and Clinical Cancer Research (R33 Clinical Trial Not Allowed) (nabór 12.2024 – 12.2025)Zamknięty9 grudnia 2025
Innovative Molecular and Cellular Analysis Technologies for Basic and Clinical Cancer Research (R61 Clinical Trial Not Allowed) (nabór 12.2024 – 12.2025)Zamknięty9 grudnia 2025
Revision Applications for Incorporation of Novel NCI- Supported Technology to Accelerate Cancer Research (U01 Clinical Trial Optional) (nabór 12.2024 – 12.2025)Zamknięty9 grudnia 2025
Innovative Biospecimen Science Technologies for Basic and Clinical Cancer Research (R61 Clinical Trial Not Allowed) (nabór 12.2024 – 12.2025)Zamknięty9 grudnia 2025
Assay Validation of High Quality Markers for Clinical Studies in Cancer (UH3 Clinical Trials Not Allowed) (nabór 10.2023 – 10.2025)Zamknięty15 października 2025
Systematic Testing of Radionuclides in Preclinical Experiments (STRIPE) (R21 Clinical Trial Not Allowed) (nabór 11.2024 – 05.2025)Zamknięty7 maja 2025
Systematic Testing of Radionuclides in Preclinical Experiments (STRIPE) (R01 Clinical Trial Not Allowed) (nabór 11.2024 – 05.2025)Zamknięty7 maja 2025
Limited Competition: NCI National Clinical Trials Network - Network Group Operations Centers (U10 Clinical Trial Required)Zamknięty24 lutego 2025
NCI National Clinical Trials Network - Network Lead Academic Participating Sites (UG1 Clinical Trial Not Allowed)Zamknięty24 lutego 2025
Limited Competition: NCI National Clinical Trials Network - Network Group Statistics and Data Management Centers (U10 Clinical Trial Required)Zamknięty24 lutego 2025
NCI National Clinical Trials Network - Network Group Integrated Translational Science Centers (UG1 Clinical Trial Not Allowed)Zamknięty24 lutego 2025

Kalendarze naborów

Dotacje na projekty rozpoczęte od 17 listopada 2024 do 17 listopada 2026; kwoty w euro po kursie Eurostatu z danego roku.

Pytania i odpowiedzi

Cancer Detection and Diagnosis Research: kiedy są nabory?
Otwarte teraz (10): Academic-Industrial Partnerships (AIP) to Translate and Validate In Vivo Imaging Systems… (7 stycznia 2027), Glioblastoma Therapeutics Network (GTN) (U19 Clinical Trial Required) (11 stycznia 2027), Limited Competition: Biospecimen Banks to support NCI National Clinical Trials Network Bi… (11 lutego 2027), …. Nabory otwierane są zwykle w listopadzie.